What happens if an applicant fails to reply within the given time period?
If an applicant fails to reply within the given time period, the application will generally become abandoned. According to 37 CFR 1.135(a): “If an applicant of a patent application fails to reply within the time period provided under § 1.134 and § 1.136, the application will become abandoned unless an Office action indicates otherwise.” It’s…
Read MoreWhat happens if an applicant fails to reply to a requirement for information in a patent application?
What happens if an applicant fails to reply to a requirement for information in a patent application? If an applicant fails to reply to a requirement for information in a patent application, the consequences can be severe. According to MPEP 704.11(b): Where the applicant fails to reply to a requirement for information, the results may…
Read MoreWhat are the consequences of failing to file an appeal brief within the specified time period?
Failing to file an appeal brief within the specified time period can have serious consequences for a patent application. The MPEP states: The failure to file an appeal brief (or a new appeal brief) within the time period set in 37 CFR 41.37(a) (or (d)) results in dismissal of the appeal. The consequences of a…
Read MoreWhat are the consequences of failing to meet accelerated examination requirements?
Failing to meet the accelerated examination requirements can have significant consequences for your patent application. According to MPEP 708.02(a): ‘If the requirements for accelerated examination are not met or if the petition is denied, the application will be returned to the examiner for processing under normal examination procedures.’ This means: Your application will lose its…
Read MoreWhere should confidential materials be delivered at the USPTO?
To ensure proper handling of confidential materials, the MPEP recommends hand-delivering them to a specific location: In order to ensure that such an envelope or container is not mishandled, either prior to reaching the Office, or in the Office, the envelope or container should be hand-carried to the Customer Window located at: U.S. Patent and…
Read MoreWhat are the requirements for a complete request for prioritized examination?
A complete request for prioritized examination must include: Certification and request form PTO/AIA/424 Required fees (prioritized examination fee, processing fee, and regular filing fees) Application must contain or be amended to contain no more than 4 independent claims and 30 total claims, and no multiple dependent claims Must be filed via the USPTO’s electronic filing…
Read MoreWhat constitutes a complete reply to a Requirement for Information?
A complete reply to a Requirement for Information under 37 CFR 1.105 must address each enumerated requirement. The MPEP states, A complete reply to a 37 CFR 1.105 requirement is a reply to each enumerated requirement for information giving either the information required or a statement that the information required to be submitted is unknown…
Read MoreHow is common ownership defined for the purposes of 35 U.S.C. 102(b)(2)(C)?
Common ownership, as defined for the purposes of 35 U.S.C. 102(b)(2)(C), refers to the complete ownership of both the subject matter that would otherwise be prior art and the claimed invention by the same person(s) or organization(s). The MPEP states: The term ‘commonly owned’ is intended to mean that the subject matter that would otherwise…
Read MoreWhat is the significance of common assignee in patent applications?
Common assignee in patent applications refers to when a reference patent or application publication and the current application are owned by the same entity. However, this common ownership does not automatically negate the need for certain legal procedures. As stated in MPEP 715.01(b): The mere fact that the reference patent or application publication which shows…
Read MoreHow does the scope of commercial success evidence relate to patent claims?
The scope of commercial success evidence must be commensurate with the scope of the patent claims. The MPEP states: Objective evidence of nonobviousness including commercial success must be commensurate in scope with the claims. (MPEP 716.03(a)) This means that the commercial success must be due to the features claimed in the patent application, not unclaimed…
Read More